Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Empagliflozin in Patients With Acute Heart Failure

NCT05392764 is registered in ClinicalTrials.gov with Juntendo University as lead sponsor.

NCT NCT05392764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05392764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Empagliflozin in Patients With Acute Heart Failure
Lead sponsor
Juntendo University
Phase
Phase 3
Overall status
Recruiting
Start date
September 10, 2022
Completion date
December 31, 2027
Enrollment
444 (estimated)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure